Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis

Sabina C. Cosulich, Hisanori Horiuchi, Marino Zerial, Paul R. Clarke, Philip G. Woodman (Lead / Corresponding author)

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Cells undergoing apoptosis exhibit striking changes in membrane organization, including plasma membrane blebbing and invagination, vacuolation and fragmentation of organelles, and alterations in the surface expression of receptors. The underlying mechanisms for these changes are unknown, though alterations in vesicular fusion are likely to play a role. Using a cell-free system based on Xenopus laevis egg extracts we have found that endosome fusion is blocked during apoptosis. Inhibition of fusion is prevented by Bcl-2 or Bcl-x(L), two negative regulators of apoptosis, or by specific inhibitors of members of the caspase family of apoptotic proteases. Selective cleavage of Rabaptin-5, an essential and rate-limiting component of endosome fusion, is responsible for the loss of fusion activity. Cleavage of Rabaptin-5 also occurs in cellular models for apoptosis. These results suggest that inactivation of Rabaptin-5 and inhibition of vesicle transport lead to fragmentation of endosomes and inhibition of the endocytic pathway during the execution phase of apoptosis. We propose that parallel changes to other membrane transport pathways would give rise to general membrane fragmentation in apoptotic cells. These changes are likely to play an important role in the generation of apoptotic bodies and their recognition by phagocytosing cells.

Original languageEnglish
Pages (from-to)6182-6191
Number of pages10
JournalEMBO Journal
Volume16
Issue number20
Early online date15 Oct 1997
DOIs
Publication statusPublished - 5 Nov 1997

Fingerprint

Endosomes
Fusion reactions
Apoptosis
Membranes
Cytophagocytosis
Transport Vesicles
Caspase Inhibitors
Cell-Free System
Xenopus laevis
Cell membranes
Blister
Caspases
Organelles
Ovum
Peptide Hydrolases
Cells
Cell Membrane
Inhibition (Psychology)

Keywords

  • Apoptosis
  • Bcl-2
  • Caspase
  • Fusion
  • Rabaptin-5

Cite this

Cosulich, S. C., Horiuchi, H., Zerial, M., Clarke, P. R., & Woodman, P. G. (1997). Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis. EMBO Journal, 16(20), 6182-6191. https://doi.org/10.1093/emboj/16.20.6182
Cosulich, Sabina C. ; Horiuchi, Hisanori ; Zerial, Marino ; Clarke, Paul R. ; Woodman, Philip G. / Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis. In: EMBO Journal. 1997 ; Vol. 16, No. 20. pp. 6182-6191.
@article{c20abad918264784a445a3a8a83d064c,
title = "Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis",
abstract = "Cells undergoing apoptosis exhibit striking changes in membrane organization, including plasma membrane blebbing and invagination, vacuolation and fragmentation of organelles, and alterations in the surface expression of receptors. The underlying mechanisms for these changes are unknown, though alterations in vesicular fusion are likely to play a role. Using a cell-free system based on Xenopus laevis egg extracts we have found that endosome fusion is blocked during apoptosis. Inhibition of fusion is prevented by Bcl-2 or Bcl-x(L), two negative regulators of apoptosis, or by specific inhibitors of members of the caspase family of apoptotic proteases. Selective cleavage of Rabaptin-5, an essential and rate-limiting component of endosome fusion, is responsible for the loss of fusion activity. Cleavage of Rabaptin-5 also occurs in cellular models for apoptosis. These results suggest that inactivation of Rabaptin-5 and inhibition of vesicle transport lead to fragmentation of endosomes and inhibition of the endocytic pathway during the execution phase of apoptosis. We propose that parallel changes to other membrane transport pathways would give rise to general membrane fragmentation in apoptotic cells. These changes are likely to play an important role in the generation of apoptotic bodies and their recognition by phagocytosing cells.",
keywords = "Apoptosis, Bcl-2, Caspase, Fusion, Rabaptin-5",
author = "Cosulich, {Sabina C.} and Hisanori Horiuchi and Marino Zerial and Clarke, {Paul R.} and Woodman, {Philip G.}",
year = "1997",
month = "11",
day = "5",
doi = "10.1093/emboj/16.20.6182",
language = "English",
volume = "16",
pages = "6182--6191",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "EMBO Press",
number = "20",

}

Cosulich, SC, Horiuchi, H, Zerial, M, Clarke, PR & Woodman, PG 1997, 'Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis', EMBO Journal, vol. 16, no. 20, pp. 6182-6191. https://doi.org/10.1093/emboj/16.20.6182

Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis. / Cosulich, Sabina C.; Horiuchi, Hisanori; Zerial, Marino; Clarke, Paul R.; Woodman, Philip G. (Lead / Corresponding author).

In: EMBO Journal, Vol. 16, No. 20, 05.11.1997, p. 6182-6191.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis

AU - Cosulich, Sabina C.

AU - Horiuchi, Hisanori

AU - Zerial, Marino

AU - Clarke, Paul R.

AU - Woodman, Philip G.

PY - 1997/11/5

Y1 - 1997/11/5

N2 - Cells undergoing apoptosis exhibit striking changes in membrane organization, including plasma membrane blebbing and invagination, vacuolation and fragmentation of organelles, and alterations in the surface expression of receptors. The underlying mechanisms for these changes are unknown, though alterations in vesicular fusion are likely to play a role. Using a cell-free system based on Xenopus laevis egg extracts we have found that endosome fusion is blocked during apoptosis. Inhibition of fusion is prevented by Bcl-2 or Bcl-x(L), two negative regulators of apoptosis, or by specific inhibitors of members of the caspase family of apoptotic proteases. Selective cleavage of Rabaptin-5, an essential and rate-limiting component of endosome fusion, is responsible for the loss of fusion activity. Cleavage of Rabaptin-5 also occurs in cellular models for apoptosis. These results suggest that inactivation of Rabaptin-5 and inhibition of vesicle transport lead to fragmentation of endosomes and inhibition of the endocytic pathway during the execution phase of apoptosis. We propose that parallel changes to other membrane transport pathways would give rise to general membrane fragmentation in apoptotic cells. These changes are likely to play an important role in the generation of apoptotic bodies and their recognition by phagocytosing cells.

AB - Cells undergoing apoptosis exhibit striking changes in membrane organization, including plasma membrane blebbing and invagination, vacuolation and fragmentation of organelles, and alterations in the surface expression of receptors. The underlying mechanisms for these changes are unknown, though alterations in vesicular fusion are likely to play a role. Using a cell-free system based on Xenopus laevis egg extracts we have found that endosome fusion is blocked during apoptosis. Inhibition of fusion is prevented by Bcl-2 or Bcl-x(L), two negative regulators of apoptosis, or by specific inhibitors of members of the caspase family of apoptotic proteases. Selective cleavage of Rabaptin-5, an essential and rate-limiting component of endosome fusion, is responsible for the loss of fusion activity. Cleavage of Rabaptin-5 also occurs in cellular models for apoptosis. These results suggest that inactivation of Rabaptin-5 and inhibition of vesicle transport lead to fragmentation of endosomes and inhibition of the endocytic pathway during the execution phase of apoptosis. We propose that parallel changes to other membrane transport pathways would give rise to general membrane fragmentation in apoptotic cells. These changes are likely to play an important role in the generation of apoptotic bodies and their recognition by phagocytosing cells.

KW - Apoptosis

KW - Bcl-2

KW - Caspase

KW - Fusion

KW - Rabaptin-5

UR - http://www.scopus.com/inward/record.url?scp=0030702877&partnerID=8YFLogxK

U2 - 10.1093/emboj/16.20.6182

DO - 10.1093/emboj/16.20.6182

M3 - Article

C2 - 9321397

AN - SCOPUS:0030702877

VL - 16

SP - 6182

EP - 6191

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 20

ER -